Sequana Medical NV
XBRU:SEQUA
During the last 3 months Sequana Medical NV insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 58% over this period (open performance analysis).
The last transaction was made on
Oct 4, 2023
by
Chauvineau Pierre
(Chief Financial Officer (CFO))
, who
bought
1.4k EUR
worth of SEQUA shares.
During the last 3 months Sequana Medical NV insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 58% over this period (open performance analysis).
The last transaction was made on
Oct 4, 2023
by
Chauvineau Pierre
(Chief Financial Officer (CFO))
, who
bought
1.4k EUR
worth of SEQUA shares.
Sequana Medical NV
Glance View
Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 60 full-time employees. The company went IPO on 2019-02-11. The firm focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
You don't have any saved screeners yet